Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.07 is 36% above its 5-year average of 2.26, near the low end of its 5-year range (0.83–15.08).
As of the fiscal period ended Tuesday, June 30, 2026. 71.72% above its 12-month average of 1.79.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.07.
CURRENT RATIO
3.07
CURRENT RATIO AVG TTM
1.79
CURRENT RATIO AVG 3Y
1.34
CURRENT RATIO AVG 5Y
2.26
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+71.72%
CURRENT VS 3Y AVG
+129.55%
CURRENT VS 5Y AVG
+35.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-18.03%
vs the sector median at left
Market Cap
$50.58M
Current Ratio
3.74
TTM Avg
0.21
3Y Avg
0.34
5Y Avg
1.39
Market Cap
$50.65M
Current Ratio
15.07
TTM Avg
17.58
3Y Avg
10.04
5Y Avg
7.84
Market Cap
$49.47M
Current Ratio
2.28
TTM Avg
1.96
3Y Avg
1.81
5Y Avg
1.76
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $50.86M | 3.07 | 1.79 | 1.34 | 2.26 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.58M | 3.74 | 0.21 | 0.34 | 1.39 |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.65M | 15.07 | 17.58 | 10.04 | 7.84 |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | 3.81 | 5.31 | 3.36 | 3.21 |
| ImageneBio Inc (IMA)vs › | $51.66M | 21.47 | 12.14 | 11.08 | 9.81 |
| Envoy Medical, Inc. (COCH)vs › | $50.99M | 1.73 | 0.89 | 0.86 | 0.91 |
| biote Corp. (BTMD)vs › | $51.61M | 1.43 | 1.27 | 3.36 | 3.09 |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.47M | 2.28 | 1.96 | 1.81 | 1.76 |
| Apollomics, Inc. (APLM)vs › | $48.97M | 0.96 | 1.17 | 2.45 | 5.02 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.81M | 3.89 | 3.98 | 6.90 | 10.09 |
Current Ratio
3.07
Quick Ratio
3.07
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.07 |
| 2026-03-31 | 1.94 |
| 2025-12-31 | 0.83 |
| 2025-09-30 | 1.53 |
| 2025-06-30 | 1.58 |
| 2025-03-31 | 1.36 |
| 2024-12-31 | 1.57 |
| 2024-09-30 | 0.83 |
| 2024-06-30 | 0.99 |
| 2024-03-31 | 1.23 |
| 2023-12-31 | 1.53 |
| 2023-09-30 | 3.04 |
| 2023-06-30 | 9.31 |
| 2023-03-31 | 1.47 |
| 2022-12-31 | 2.11 |
| 2022-09-30 | 3.49 |
| 2022-06-30 | 4.13 |
| 2022-03-31 | 7.77 |
| 2021-12-31 | 9.06 |
| 2021-09-30 | 13.54 |
| 2021-06-30 | 15.08 |
| 2021-03-31 | 13.06 |
| 2020-12-31 | 5.40 |
| 2020-09-30 | 6.92 |
| 2020-06-30 | 0.89 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.20 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
